Kolkata, February 08, 2023: Staying always ahead in the technology curve, Apollo Multispeciality Hospitals Kolkata acquired da Vinci Xi Robot for the first time in Eastern India.Being the first hospital in Eastern India to bring da Vinci Si Robot a decade back, it has now moved a step ahead with furthermore latest technology.The Xi Robot can assist surgeons in intervention in gynecology, urology, oncology, cardiology, gastroenterology and others. The Robot is extremely helpful for accessing the body parts in lower abdomen where it’s difficult to reach with bare hands.The da Vinci Xi robot allows surgeons to perform minimally invasive surgeries with enhanced visibility and dexterity, allowing for accurate movements and over-all improved patient safety. It maintains high levels of precision with less time in docking machine on the patient’sbody before the surgical procedure. Patients get benefitted from smaller scar, shorter stay in hospital with minimal blood loss and faster recovery.On this note Mr Rana Dasgupta, CEO- Eastern Region, Apollo Hospitals Group, said, “Being among the best healthcare provider in Eastern India, we always focus on ensuring the latest technologies for our patients. This is yet another endeavor towards ease of treatment for all our patients.”Present at the occasion, Dr Surinder Singh Bhatia, DMS, Apollo Multispeciality Hospitals Kolkata expressed, “Robotic surgery is the next generation of minimally invasive surgery. Surgical robots are extremely beneficial for many minimally invasive surgeries as it helps in precise movements of surgical instruments beyond human ability in a small surgical area. da Vinci Xi is the latest robot with the modern functionality to help the surgeons operate as well as the patients safety and fastest recovery.”The whole procedure of Robotic surgery involves the doctor sitting on the console with the monitor displaying the surgical area and the robotic arms assisting the doctor for operating. One of the arms holds a high magnification 3D camera which is inserted into the abdomenthrough one of the key holes and provides a high-definition, magnified (12×), 3-D view of the surgical site. The other mechanical arms have surgical instruments attached to it that are designed to mimic the movement of the human hands and wrists.The primary benefit of Robotic surgery is minor incisions and hence, recovery is faster with much lesser complications. It also comes with less pain, lesser or no chance of infection as the incision is much smaller than the usual size of cut, less hospital stay and early recovery andback to normal life.

Kolkata, June 2, 2023: For the first time in India, Apollo Multispeciality Hospitals Kolkata brings the comprehensively connected 5G Ambulance that would transform access to healthcare and save lives in emergency situations. The custom-designed, state-of-the-art 5G-connected Ambulance is equipped with the latest medical equipment, patient monitoring applications, and telemetry devices that transmit the patient’s health data to the hospital with low latency. In addition, it is also equipped with onboard cameras connected to the ultra-fast and low-latency 5G network. The integrated connected care technology solution is provided by HealthNet Global Limited, who are world leaders in providing different health tech solutions. It is an affiliate of Apollo Hospitals.When a critical patient is en route to the hospital and every second makes a difference, the 5G-connected Ambulance acts as an extension of the emergency room and enables the following:• Always connected to the hospital: The high-speed, low-latency 5G network relays the geo-location of the ambulance to the hospital’s command centre to ensure the nearest ambulance reaches the critical patient to save the Golden Hour time. Also, the ambulance transmits the patient’s complete telemetry data, including vitals, in near real-time to doctors and experts at the hospital. This allows the doctors at ER to make quicker decisions and advise paramedics in the ambulance to administer required aid while on the move. It also prepares the hospital staff to better manage the patient on arrival and save precious time.• Transports ER Specialist doctors virtually to the ambulance: With near real-time camera feed available, the doctors and paramedics in the ambulance can use the cameras to collaborate with the ER specialist doctors at the hospital who are equipped with advanced technologies to undertake basic procedures, if necessary. The doctors can virtually guide the paramedic to carry out the procedure and save precious lives.Present at the occasion, Dr K Hari Prasad, President-Hospitals Division, Apollo Hospitals Enterprises Limited, said, “Apollo Hospitals has always strived to provide access to the community. The 5G-connected ambulances use advances in technology to provide immediate access to the seriously ill and injured. It enables advanced care from the spot where the patient is through the journey to the hospital and in the Emergency room. This is truly a pathbreaking initiative and will be an important tool in saving precious lives.”On this note, Mr Rana Dasgupta, CEO-Eastern Region, Apollo Hospitals Group, said, “Keeping up with our tradition to always offer modern healthcare, we bring the 5G-connected ambulance to save the lives of critical patients and utilize the Golden Hour to the benefit of patients. The ambulance will provide real-time images and data due to super-fast streaming and the image clarity would also be very high due to the 5G technology. Treatment will now begin when the patient is on the way to the hospital.”Also present at the occasion, Dr Surinder Singh Bhatia, Director Medical Service, Apollo Hospitals, Kolkata, said, “The criticality of the ‘Golden Hour’ is well known and it can mean the difference between life and death for seriously ill or trauma patients in an emergency. The Golden Hour is impacted by the facilities in an ambulance and the distance from the hospital. Studies show that longer journey to the hospital is associated with an increased risk of mortality, with a 10‐km increase in straight‐line distance associated with around a 1% absolute increase in mortality. Instead of pre-hospital management, we may say that with the 5G-connected ambulance, it is the hospital on wheels that reaches the patient to start early management. These insights propelled us to bring the 5G-connected ambulance to utilize the disruption-free, lag-free connectivity it provides.”Dr Arijit Bose, Senior Consultant & Head Department of Emergency Medicine, Apollo Multispeciality Hospitals, Kolkata, added, “The super-fast streaming and the image clarity of the 5G-connected ambulance would help us to save many lives as timely treatment can be started even in the transit phase in the ambulance itself. Along with medication, if needed, interventions and intubations can also be done in the ambulance itself.”

A unique application will facilitate TB treatment adherence through SMS reminders, interactive voice calls and counseling servicesAn utility solution to curb rampant spread of the diseaseHyderabad, March, 2015: ‘The Union’ (International Union Against Tuberculosis and Lung Disease) in collaboration with the Apollo Hospitals, Hyderabad, is launching a pilot project to integrate TB treatment rendered in the private healthcare sector with the National TB Control Program through a unique web-based software application. This application facilitates improved tuberculosis notification, patient adherence to treatment and ensuring better outcomes.The innovative software links the private health facility with Government of India’s TB notification portal Nikshay. It simultaneously supports TB patients for treatment adherence through messages, interactive voice calls and counseling services. The launch of this pilot project using the application to control and treat TB was announced by Ms. Sangita Reddy, Dy. Managing Director, Apollo Hospitals Group; Dr. Sarabjit Chadha, Project Director, The Union – India; Dr. Sai Praveen Haranath, Senior Consultant Pulmonologist, Apollo Health City; Dr Dilip Mathai, Dean, Apollo Institute of Medical sciences & Research; Dr. Lavanya Nutankalva, Consultant Infectious Diseases and Dr. Suneetha Narreddy, Consultant Infectious Diseases, Apollo Health City, at a Press Conference on Friday at Apollo Health City.Tuberculosis is gaining epidemic proportions causing nearly 1.5 million deaths each year, mostly in developing countries. According to statistics available, India alone accounts for a fourth of the new cases of TB detected globally every year, India has 2.2 million new cases of the 8.6 million worldwide. This airborne disease kills about 1000 Indians every day and is therefore considered as India’s biggest health crisis. One of the reasons aggravating the rise in incidence is lack of integration of TB program with the private healthcare sector, besides let up on constant vigilance, effective surveillance and monitoring. Often patients reporting at private clinics or hospitals after initial relief from the disease are off the treatment radar, resulting in non-compliance of treatment, while that being the crucial period for vigorously follow up and monitoring. Such patients also end up spreading the disease in the community.The World Health Organization (WHO) through its Stop TB Strategy, has been engaging relevant health-care providers through public-private and public-public mix approaches in tuberculosis care and control. Well known global organization working in this arena – The Union, in collaboration with theLilly MDR-TB partnership is implementing a project to systematically involve private health care providers in delivering effective and quality TB services in India.As part of this initiative Apollo Hospitals is working on improving tuberculosis notification, adherence to treatment and bettering outcomes, in partnership with The Union and has launched a website – http: //www.ahtts.in/. The software linked with the Nikshay project, helps in reminding patients through regular SMS to take medicines, in addition, the Integrated voice response tool monitors the treatment adherence.“Non-compliance to treatment increases the risk of drug resistant tuberculosis, which is a grave concern in India. Automated management will improve care and save lives. It is no more a question of can we eliminate TB – it’s more a call to action to definitively rid the world of this deadly disease,” says Ms Sangita Reddy. We are launching the pilot project today and will roll it out to other locations in thecoming weeks. She said, TB has a solution, but we being not in a position to control it is sad. Referring to TB prevalence in India, she said, the problem is large, solution is strong but public awareness is low and requested media to work towards increasing awareness levels. Apollo Hospitals is committed, we will run an active TB program. 70 % of the patients are falling out of treatment regimen, intervention through technology in the form of this application will ensure better adherence. The application will be test piloted and perfected at Apollo Hospitals, Jubilee Hills, before rolling it out to other Group hospitals subsequently, she said.Dr. Sarabjit Chadha said, half of the TB patients are getting treated in private healthcare sector, often there is no follow up mechanism for these patients. This software captures essential details of such patients, notifies the patient’s ailment. It interacts with the patient constantly through daily SMS reminders for consuming the medication dosage, checks on his treatment adherence through IVR every third day and counselors at Apollo Hospital will talk on phone and visit if necessary those patients who are not sticking to the treatment protocol and counsel them to get back on treatment track. We will scale this program to other private hospitals who can replicate, on successful completion of this pilot project. He said, off-late TB diagnosis has been effective, however modern dwellings and crowding in urban centers is giving a fillip for TB to spread rapidly, while reminding of the saying ‘TB anywhere is TB everywhere.’ Also high incidence of drug resistance due to skipping of the treatment protocol is a cause for concern. He said, we are currently working on a shorter treatment regimen called STREAM (Standardized Treatment) Regimen for TB treatment, to bring down the treatment duration from the current two years to nine months. We have done pilot testing of this in Bangladesh and are currently treating TB patients in four countries, Vietnam, Mongolia, Ethiopia and South Africa, with this regimen with 85% cure rate. We would complete our trials and introduce it in India by 2016. He said, a couple of companies abroad have developed drugs to treat Multiple drug resistance, which are currently not available in India.Dr. Sai Praveen Haranath said, any cough which doesn’t subside over a period of two weeks needs to be got checked. People may contract TB, which may remain dormant for extended period, but will become active when the immune system is weak or one is on drugs to suppress immunity. He said, the productivity loss on account of TB in India alone is estimated to be $25 bn.Dr Dilip Mathai said, TB is a chronic ailment, often patients report to doctors late, diagnosis is easy and if one takes medication can be cured in six months in 98% of the cases.About Apollo HospitalsIt was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospital in Chennai. Now, as Asia largest and most trusted healthcare group, its presence includes 8,488 beds across 51 Hospitals, 1,586 Pharmacies, 92 Primary Care and Diagnostic Clinics, 100 Telemedicine units across 10 countries. Health Insurance services, Global Projects Consultancy, 15 colleges of Nursing and Hospital Management and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research and the first Proton Therapy Center across Asia, Africa and Australia.In a rare honor, the Government of India issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 28 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.About the UnionThe mission of International Union Against Tuberculosis and Lung Disease (The Union) is to bring innovation, expertise, solutions and support to address health challenges in low and middle-income populations. Headquartered in Paris, The Union is the only international voluntary scientific organisation with partners providing a neutral platform to fight TB, HIV, asthma, tobacco and lung disease.Established in 1920, The Union today is both a non-profit institute with five scientific departments and several offices worldwide; and a federation of close to 3,000 organisations and individuals. Its scientific departments focus on tackling major health challenges including: Tuberculosis, HIV, Lung health (including Child Lung Health), Non-communicable diseases, and Tobacco Control. Technical assistance, research, education and advocacy form the core of The Union’s activities and support to more than 170 countries and programmes across the world.The Union is most widely known for developing the DOTS (Directly Observed Treatment, Short Course) strategy for treating and controlling tuberculosis. Internationally recommended and adopted by the World Health Organization, The Union model has been used to treat 37 million people around the world. For more information, please see www.theunion.org.About The Union South-East AsiaThe Union South-East Asia Office (USEA), based in New Delhi, works in Bangladesh, India, Indonesia and other countries across the region, drawing on a network of consultants and strong partnerships with governments, civil society, corporations and international agencies. Established in 2003 as The Union’s first regional office, today it brings global experience and expertise to its work as well as efficiency and energy to The Union’s services across the region. USEA has a dedicated staff with technical expertise which reflects the Union’s emphasis on tuberculosis, HIV, lung health, tobacco control, non-communicable diseases and research.Since 2009, USEA has managed Project Axshya, a Global Fund supported project designed to enhance access to TB services by vulnerable and marginalised populations in 300 districts across 21 states of India. Other key projects include tobacco control efforts in India, Nepal and Bangladesh through the Bloomberg Initiative to reduce tobacco use; and the Eli-Lilly supported project to expand sustainable TB control in India. USEA also coordinates trainings to build capacity in the management of TB and MDR-TB, operational research, programme management and other skills.

Kolkata, February 8th, 2024 – In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have uccessfully complete CAR-T cell program and to further augment it, the group will now provide access to ‘Made in India’ CAR-T cell therapy, beginning with NexCAR19™ (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.CAR-T cell therapies, often known as ‘living drugs’ involve the extraction of a patient’s T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are then genetically modified by a safe vehicle (viral vector) in a controlled laboratory setting, so that they express modified connectors on their surface called Chimeric Antigen Receptors (CARs). These CARs are specifically designed to recognize a protein which is abnormally expressed on certain cancer cells. They are then multiplied to a desired dose, and infused directly in to the patient.CAR-T cell therapies have gained global recognition for their unparalleled success in transforming the lives of patients with challenging B-cell malignancies. Having treated over 25,000 patients worldwide, have benefited from this therapeutic model.Dr. Anupam Chakrapani, Senior Consultant – Haematology & BMT Specialist, ACC, Kolkata, said, “The successful treatment of three patients using CAR-T Cell therapy at the commercial level, represents a significant leap forward in our fight against B-cell lymphomas and acute lymphoblastic leukaemia. These cases highlight the efficacy and potential of this transformative therapy in providing new hope for patients facing these challenging conditions.”Sharing insights into the success of the program, he further added, “Having successfully treated patients with imported drugs, we are now poised to treat them with the indigenously built therapy.”Dr. Rajat Bhattacharyya, Senior Consultant – Pediatric Haematology, ACC, Kolkata, said,  “The successful implementation of CAR-T Cell therapy represents a pivotal moment in the advancement of cancer treatment in India. Treating patients with this revolutionary therapy showcases the potential and efficacy of this transformative approach in addressing challenging B-cell malignancies. This milestone signifies a new chapter in our fight against cancer, offering renewed hope and possibilities to those battling these conditions.On the occasion, Mr. Rana Dasgupta – CEO Eastern Region, ACC Kolkata, Apollo Hospitals Enterprises Limited, said, “Embarking on a pioneering journey, Apollo Cancer Centres has achieved a remarkable feat in the realm of cancer treatment. With successful treatments, our commitment to advancing CAR-T Cell Therapy is unwavering. Being the first private hospital in India to achieve success in this transformative therapy sets a new benchmark, reinforcing our dedication to groundbreaking healthcare. The indigenously built CAR-T treatment, NexCAR19, reflects our commitment to accessible and effective solutions. Apollo Cancer Centres is not just changing the narrative; we’re rewriting the possibilities of giving better treatment outcome for cancer patients across India and beyond.”Apollo Cancer Centres has been a trailblazer in the Indian medical community, consistently introducing pioneering medical infrastructure and achieving numerous milestones. The introduction of CAR-T Cell therapy represents a new era for cancer treatment in the country.

Kolkata, February 29, 2024: Apollo Multispeciality Hospitals Kolkata, a leading healthcare provider renowned for its commitment to innovation and patient-centric care, proudly launched its newest facility – the Apollo Genomics Institute (AGI). This significant milestone marks Apollo’s continued dedication to advancing genetic healthcare and personalised medicine.The Apollo Genomics Institute, initially established in Mumbai, Delhi, Hyderabad, and Chennai, has now extended its reach to Kolkata. It aims to address the increasing prevalence of genetic disorders and the need for early disease identification and prevention in the region.The launch of its Kolkata branch featured distinguished speakers including Dr. Anupam Sibal, Group Medical Director of the Apollo Hospitals Group; Dr. Mahesh Kumar Goenka, Director of Gastrosciences and Medical Education; and Dr. Rohit Bhojaraj, Vice President of Children, Genomics, and Clinical Operations. Also present were Mr. Rana Dasgupta, CEO-Eastern Region, Apollo Hospitals Group; Dr. Surinder Singh Bhatia, Director Medical Services – Eastern Region; and Dr. Saswati Mukhopadhyay, Consultant Clinical Geneticist at Apollo Multispeciality Hospitals, Kolkata. The event also included a symbolic lamp-lighting ceremony, marking the beginning of a new era in genomic medicine.Regarding the inauguration of the institute at Kolkata, Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Group, said, “India is a highly diverse heterogeneous country, and as a result, genomic medicine could have transformative potential. With decreasing infant mortality rates, genetic disorders are emerging as an important group of diseases. According to a 2021 report by the Ministry of Health and Family Welfare, the number of diseases in India that are globally recognised as rare diseases encompass around 7,000 to 8,000 disorders.”Elaborating on the increasing demand for genomic medicine, she further added, “Today, as our population gets more health conscious, we’re also seeing increased awareness amongst individuals around the value of genomic tests in the prevention and diagnosis of non-communicable diseases (NCDs) and genetic diseases, such as diabetes, cancer, and cardiovascular disorders amongst others. The expansion of the Genomics Institute is a critical step towards the prevention and management of NCDs, which continues to be a significant public health challenge in India and around the world.”Ms. Suneeta Reddy, MD, Apollo Hospitals Group, said “At Apollo, we believe that patients need to be brought to the forefront of the decision-making process concerning their health journey. Constantly increasing the availability of real-world data sources coupled with patient-centric analytics offer deeper insights into how they are diagnosed, treated, and beyond. Genomics is one such area. On the back of increasing NCDs, the greater availability of patient-level data helps practitioners better understand the patient journey. This also enables personalisation in medicine by leveraging genetic insights, immensely impacting decisions made regarding the prevention, diagnosis, and treatment of diseases. At Apollo Genomics Institute, our focus on preventive care and personalised medicine underscores our commitment to a more resilient and healthier society.”India has 20 per cent of the world’s global population. It, however, contributes only 0.2 per cent of the global genetic database. Apollo Genomic Network is planning to launch a genomic variant database to collate and secure the genomic data generated securely.  The Pan-Apollo Genomics Network is also actively involved in academics and research activities. AGI holds weekly case discussions, peer-to-peer learning, monthly grand rounds, journal clubs and healthcare seminar series.Since NCDs continue to be one of the leading causes of death and suffering, contributing to 65 per cent of deaths in India, Apollo is committed to making preventive healthcare a national priority. The Apollo Genomics Institute’s ultimate goal is to transform the future of healthcare in India by providing access to precision and personalised medical care.

With your support Apollo Hospitals has again been ranked as the Best Hospital in the Hyderabad & Chennai. Times of India Ranking published once again reiterates the leadership position of Apollo Hospitals. Look forward for your continued support.

March 1, 2024: Apollo Multispeciality Hospitals, Kolkata, marked a significant milestone today with the inauguration of the Apollo Tele-ICU Spoke at Tridev Hospital, located in Deoghar, Jharkhand. The inauguration ceremony took place today at Tridev Hospital in Deoghar.The event was graced by esteemed guests including Mr. Rana Dasgupta, CEO Eastern Region, Apollo Hospitals Group; Dr. Ravi Prakash Mahajan, Director, Critical Care Integration & Transformation, Apollo Hospitals Group; Dr. Rakesh Kumar, Director & Dr. NamitaJoint Director – Tridev Hospital, ; Dr. Surinder Singh Bhatia, Director of Medical Services at Apollo Multispeciality Hospitals, Kolkata; and Dr. Arpan Chakraborty, Senior Consultant, Critical Care & ECMO Physician, Apollo Multispeciality Hospitals, Kolkata.The newly inaugurated Tele-ICU is equipped with state-of-the-art technology, including 360-degree cameras and other advanced gadgets designed to monitor patients’ vital signs. This 24×7 real-time patient monitoring system allows for the prompt and efficient sharing of patient data with the Critical Care team, ensuring timely medical intervention. Additionally, the Tele-ICU offers critical care support with superspeciality consultation back-up, further enhancing patient care and outcomes.Tele-ICU services leverage cutting-edge technologies such as video conferencing, remote monitoring, and electronic medical records to provide exceptional care to critically ill patients, irrespective of their geographical location. This initiative is very important for Deoghar. The establishment of the tele-ICU at Tridev Hospital marks a significant leap forward in healthcare accessibility, particularly for the pilgrims who converge from across India during Shiv Ratri. During critical medical situations, the Tele-ICU will serve as a crucial resource, guaranteeing swift medical aid and necessary interventions, thereby emerging as a lifeline for pilgrims in urgent need of medical attention.Mr. Dasgupta said, “This tele-ICU initiative at Tridev Hospital represents a vital step forward in extending medical care to pilgrims during their holy journey to Deoghar. In times of need, it will serve as a beacon of hope, providing timely interventions and support, ensuring their well-being and safety.”The inauguration of the Tele-ICU at Tridev Hospital represents Apollo Hospitals Group’s commitment to leveraging technology to expand access to high-quality healthcare services across geographies.

Apollo Pediatric Cardiology team accomplishes a rare milestone of performing 100 complex Fontan repairs – for Single ventricle defect, a complex condition.In India 3000 to 5000 children are born with single ventricle defects, out of about 50,000 children born with congenital heart disease every year. Single ventricle defects are complex heart diseases with very large holes in the heart and one of the lower chambers of the heart ( the ventricle) is often rudimentary. Such children would need multiple operations called Fontan Repairs. In the last four years the Pediatric Cardiology team performed 100 Fontan Operations with a success rate of 98%. This is one of the highest number done in this city and the success is comparable to the best centers across the world.Mr. Ravi Krishnan, CEO & Founder Stepathlon, found SACHi as a comprehensive program that addresses all aspects of pediatric care specially prevention , early detection, treatment, funding and follow up care. Hence his company chose to support SACHi in its endeavors.

April 30, 2024 — Apollo Multispeciality Hospitals Kolkata recently convened a press conference in Guwahati, shedding light on the latest advancements in the treatment of Structural Heart Disease. Led by esteemed Consultant, Dr. Sumanto Mukhopadhyay, the event aimed to raise awareness about the complexities of Structural Heart Disease and the evolving landscape of treatment options available to patients.Structural Heart Disease encompasses a range of defects or disorders in the heart’s structure, whether congenital or acquired later in life. While initially asymptomatic in some cases, warning signs such as breathing difficulty, chest pain, dizziness and fatigue often prompt individuals to seek medical attention.Dr. Sumanto Mukhopadhyay emphasised the pivotal role of preventive measures, highlighting the significance of healthy lifestyle choices such as nutritious eating habits and regular exercise in mitigating the risk of coronary heart disease, which differs from structural heart issues.During the conference, attendees gained insights into the intricate workings of the heart and how structural abnormalities can impact its functionality. With the heart beating approximately 100,000 times daily, ensuring optimal structural integrity is paramount for maintaining overall health and well-being.In terms of treatment modalities, the discussions underscored significant progress in the field. While open-heart surgery remains a necessity in certain cases, minimally invasive catheter-based interventions are revolutionizing patient care, offering reduced complications and quicker recovery times.Dr. Sumanto Mukhopadhyay who is internationally renowned for percutaneous treatment of structural heart diseases, elucidated on various treatment approaches tailored to individual patient needs, ranging from medication to complex interventions. For instance, medications like diuretics may be prescribed to mitigate the symptoms initially, while procedures, including trans-catheter aortic valve implantation or mitral or tricuspid repair ( Mitraclip/ Triclip)address specific structural abnormalities even in very high risk patients.The press conference served as a platform to educate both the public and healthcare professionals on the complexities of Structural Heart Disease and the evolving treatment landscape. By fostering dialogue and sharing insights, Apollo Multispeciality Hospitals Kolkata reaffirms its commitment to advancing patient care and improving outcomes in cardiovascular health.

Apollo hospitals, Health City, Visakhapatnam In Association with OGSV has conducted CME & live Workshop on Robotics in Gynecology on 12th March 2023 which is first of its kind in Andhra Pradesh.Nearly 150 delegates – Gynecologist from all over Andhra Pradesh have attended this program.Dr. Sasi Prabha Senior Gynecologist form Visakhapatnam has inaugurated the program as chief guest.Dr. Rooma Sinha Senior Consultant Laproscopic & Robotic Surgeon from Apollo Hospitals, Jubilee hills, Hyderabad along with the team of  gynecologists and Laproscopic d robotic surgeons from Apollo Hospitals, Visakhapatnam.Dr. Kiranmai Gottapu Senior Consultant  Dr. Sreedevi Matta Senior Consultant, Dr Vidya Konduri Consultant have demonstrated complex live surgeries Robotic myomectomy, Robotic hysterectomy and shared their vast experience in the field with delegates.On this occasion Mr Y. Subramanyam CEO and Mr. Ramachandra J COO Apollo Hospitals  said that Apollo Hospitals is always at the fore front in bringing advanced treatments to its patients across India. They also stated that Apollo Hospitals, Health City is fully equipped with state of art Laparoscopic/ Robotic Facility and Experienced surgeons to offer the best minimal invasive surgical care to our patients.The first case in Benign Gynaecology in the state of Andhra Pradesh was done at Apollo Hospitals, Visakahapatnam under the head of Dr. Kiranmai Gottapu & they have already done near 100 surgeries from various departments like gynecology, Urology general and GI Surgery and Oncology.

The Swachh Bharat activity by our employees was successfully executed on the morning of the Republic Day.The buzz started at 5.45am. More than 500 volunteers (HODs, Consultants and Employees) kick-started the cleanliness drive led by our JMD Ms Sangita Reddy at 7.00am. White T Shirts and Caps gave us the look of Team Apollo.The Peripheral road encircling the Hospital was swept, Bleached and Painted in 100 minutes. Heaps of mud, outdated Banners and posters, worn-out tarpaulin shades, ownerless scrap on the road side were removed and disposed into the GHMC waste carrier.The Urinated zone near the substation (back gate) was watered and bleached with the help of GHMC tankers. Pools of water were spread and dry mud was distributed to even out the urinated zone.Pavements bore a new look with the black and white contrast. In all, we cleaned our vicinity and made ourselves a promise to practice cleanliness.Our JMD wants us to sustain this effort by regular initiatives such as these. Our VP- HR elaborated on keeping up this tempo and making Swachh Bharat a monthly activity by various Business verticals within the premises.It was a humble beginning and it began with a Roar. Let us take Pride in continuing this “coming together with a purpose time and again for a better cause.

Renowned Urologist Dr. Saurabh Chipde is now associated with Apollo Hospitals, IndoreApollo Hospitals recently announced that senior Urologist, Dr Saurabh Chipde has joined as part of the Urology and Transplant Institute of Apollo Hospitals, Indore. A well-recognized clinician, researcher and teacher, Dr Chipde brings with him experience not just spanning super-specialty Urology care but also the latest which includes Robotics and Transplant. Dr Chipde, an AIIMS, New Delhi and SGPGIMS alumni has undergone specialized training in Robotic Assisted Surgery from the world renowned institute for Robotics RPCI, New York, USA.Dr Chipde said, “I am extremely happy to come on board Apollo Hospitals and be part of the Urology and transplant Institute. Apollo Hospitals has been at the forefront in bringing the latest cutting-edge medical technology to the country and Urology and Transplant as a speciality has gained immensely from the contribution from Apollo Hospitals in its advancements. While I will be primarily based out of Vijay Nagar situated Apollo Hospitals; for Robotics where I’ve a personal interest and specialization I will be also accessing and operating at the Navi Mumbai based Apollo Hospitals.”Recipient of four Urology Society Award and youth section fellowship from Urology Association of Asia (UAA) Dr Chipde is amongst the few in the region to have over 25 publications in many reputed national and international journals. Dr Chipde’ interest includes Endourology and a specialist in performing scarless surgeries of kidney stone and prostate, Advanced Key Hole Surgery, Robotic Urology, Kidney Transplant and surgeries for Dialysis access.Abhilash Pillai, Unit Head, Apollo Hospitals Indore said, “Our goal at Apollo Hospitals is to offer world-class health care that is accessible and affordable. We are pleased to welcome Dr Saurabh Chipde to our team of experienced clinicians and are sure that patients at Apollo Hospitals, will benefit from his experience and expertise and receive the best in Urology care”